Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

Office of Research & Development

 print icon sign up for VA Research updates

Funded Project Details - FY2021




Project Number:

I01CX001156-01A1
Title: Does screening for HCC reduce HCC-related mortality in HBV-infected Veterans?
Principal Investigator:

George N. Ioannou

Location: Seattle, WA
Congressional District Code: 7
Research Service: Clinical Science R&D
Project Period: July 2015 - December 2020
FY 2021 Funding Amount: $0
Total Award Amount
(all years):		 $585,230
Abstract: View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER

Excerpt:

Hepatocellular carcinoma (HCC) is one of the most important clinical complications of chronic hepatitis B virus (HBV) infection. It has been suggested that HBV-infected patients should undergo screening for HCC with abdominal ultrasonography and possibly also serum alpha fetoprotein (AFP) testing. However, it is unclear if screening HBV-infected patients with these two tests reduces HCC-related mortality. Our Specific Aims are to: 1. Determine whether screening for HCC with abdominal ultrasono...


Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.